COGT – cogent biosciences, inc. (US:NASDAQ)
Stock Stats
News
Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in NonAdvanced Systemic Mastocytosis
JPMorgan Raises Cogent Biosciences (COGT) PT to $67 on Sector Model Update [Yahoo! Finance]
Cogent Biosciences (NASDAQ:COGT) was upgraded by analysts at Wall Street
Cogent Biosciences (NASDAQ:COGT) had its price target raised by analysts at JPMorgan Chase & Co. from $65.00 to $67.00. They now have an "overweight" rating on the stock.
Cogent Biosciences: Time For A Pause [Seeking Alpha]
Form 4 Cogent Biosciences, Inc. For: Dec 26 Filed by: Kearns Evan
Form 4 Cogent Biosciences, Inc. For: Dec 26 Filed by: Robinson John Edward
Form 4 Cogent Biosciences, Inc. For: Dec 26 Filed by: Green John L.
Form 4 Cogent Biosciences, Inc. For: Dec 26 Filed by: Sachs Jessica
Form 144 Cogent Biosciences, Inc. Filed by: Sachs Jessica
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.